Bioxtreme receives FDA clearance for DeXtreme rehabilitation robotic device
Evidence notes
- Bioxtreme's DeXtreme neurorehabilitation robotic device is listed as FDA approved.
- The listed FDA number is 10062549.
- The approval date is listed as February 17, 2020.
Company context
Bioxtreme develops robotic rehabilitation systems for upper-limb and hand recovery in patients with neurological injuries including stroke and traumatic brain injury. Its systems use precision robotics, immersive therapy tasks, real-time movement sensing, and proprietary error augmentation forces to support motor relearning.